Catalyst Wire Dossier Catalyst Wire Dossier

Glial cell line-derived neurotrophic factor (GDNF)

glial cell line-derived neurotrophic factor
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glial cell line-derived neurotrophic factor (GDNF), covering 2008-03-04 to 2008-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy [Phase 2]

See pricing